Abstract IA3: In tumor screening for novel targets in papillary serous ovarian cancer

Abstract

Abstract In search of new, potential therapeutic target proteins in primary ovarian cancer cells, we have performed in-tumor shRNA screens in an established, human ovarian cancer (ov ca) cell line growing either subcutaneously or intraperitoneally in immunologically incompetent mice. Validation tests were then performed on the confirmed hits in viability/proliferation assays performed, in parallel, in at least two, cultured primary papillary serous ov ca cell strains each of which was generated by direct intraperitoneal injection of primary, patient- derived ov ca cells. The lentiviral shRNA library used contained ~8,000 hairpins, collectively directed against all known human protein kinases and a number of established human oncoproteins. Approximately 40 hits were detected and confirmed in this study, in which the screen involved deep sequencing of DNA isolated from residual tumor material growing in multiple animals. Here the search was for any hairpins that were selectively and specifically depleted from these DNA samples. Currently, we are focusing on two, new hits in this effort with special attention to their effects on primary human ov ca cell tumor formation in nude mice. Citation Format: Maria Giuseppina Baratta, Maria Giuseppina Baratta, Joyce Liu, Joyce Liu, Yaara Zwang, Yaara Zwang, Yaara Zwang, Anna Schinzel, Anna Schinzel, Ronny Drapkin, Ronny Drapkin, William Hahn, William Hahn, William Hahn, David M. Livingston, David M. Livingston. In tumor screening for novel targets in papillary serous ovarian cancer. [abstract]. In: Proceedings of the AACR Special Conference on Advances in Ovarian Cancer Research: From Concept to Clinic; Sep 18-21, 2013; Miami, FL. Philadelphia (PA): AACR; Clin Cancer Res 2013;19(19 Suppl):Abstract nr IA3.